Control of infection with Leishmania major in susceptible BALB/c mice lacking the common γ-chain for FcR is associated with reduced production of IL-10 and TGF-β by parasitized cells

Journal of Immunology

Volumn 174, Issue 10, 2005, Pages 6340-6345

  Padigel, Udaikumar M ^a,b   Farrell, Jay P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FC RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; PROTOZOON ANTIBODY; TRANSFORMING GROWTH FACTOR BETA;

AMASTIGOTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENETIC SUSCEPTIBILITY; IMMUNE RESPONSE; INFECTION CONTROL; INFECTION SENSITIVITY; INFLAMMATORY CELL; LEISHMANIA MAJOR; LEISHMANIA PIFANOI; MACROPHAGE; MOUSE; NONHUMAN; OPSONIZATION; PARASITISM; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

EID: 18644364718     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.10.6340     Document Type: Article

References (35)

1. Pleass, R. J., and J. M. Woof. 2001. Fc receptors and immunity to parasites. Trends Parasitol. 17: 545-51.
2. Raghavan, M., and P. J. Bjorkman. 1996. Fc receptors and their interactions with immunoglobulins. Annu. Rev. Cell. Dev. Biol. 12: 181-220.
3. Ravetch, J. V., and J. P. Kinet. 1991. Fc receptors. Annu. Rev. Immunol. 9: 457-92.
4. Daeron, M. 1997. Fc receptor biology. Annu. Rev. Immunol. 15: 203-234.
5. Qiu, W. Q., D. de Bruin, B. H. Brownstein, R. Pearse, and J. V. Ravetch. 1990. Organization of the human and mouse low-affinity FcγR genes: duplication and recombination. Science 248: 732-5.
6. Askenase, P. W., and B. J. Hayden. 1974. Cytophilic antibodies in mice contact-sensitized with oxazolone: immunochemical characterization and preferential binding to a trypsin-sensitive macrophage receptor. Immunology 21: 563-76.
7. Heusser, C. H., C. L. Anderson, and H. M. Grey. 1977. Receptors for IgG: subclass specificity of receptors on different mouse cell types and the definition of two distinct receptors on a macrophage cell line. J. Exp. Med. 145: 1316-27.
8. Diamond, B., B. R. Bloom, and M. D. Scharff. 1978. The Fc receptors of primary and cultured phagocytic cells studied with homogeneous antibodies. J. Immunol. 121: 1329-33.
9. Gessner, J. E., H. Heiken, A. Tamm, and R. E. Schmidt. 1998. The IgG Fc receptor family. Ann. Hematol. 76: 231-48.
10. Takai, T. 1996. Multiple loss of effector cell functions in FcRγ-deficient mice. Int. Rev. Immunol. 13: 369-381.
11. Takai, T., M. Li, D. Sylvestre, R. Clynes, and I. V. Ravetch. 1994. FcRγ chain deletion results in pleiotrophic effector cell defects. Cell 76: 519-29.
12. Barnes, N., A. L. Gavin, P. S. Tan, P. Mottram, F. Koentgen, and P. M. Hogarth. 2002. FcγRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 16: 379-89.
13. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166: 1141-7.
14. Kima, P. E., S. L. Constant, L. Hannum, M. Colmenares, K. S. Lee, A. M. Haberman, M. J. Shlomchik, and D. McMahon-Pratt. 2000. Internalization of Leishmania mexicana complex amastigotes via the Fc receptor is required to sustain infection in murine cutaneous leishmaniasis. J. Exp. Med. 191: 1063-1068.
15. Brown, D. R., and S. L. Reiner. 1999. Polarized helper-T-cell responses against Leishmania major in the absence of B cells. Infect. Immun. 67: 266-70.
16. Colmenares, M., S. L. Constant, P. E. Kima, and D. McMahon-Pratt. 2002. Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody. Infect. Immun. 70: 6597-605.
17. Sacks, D. L., and P. V. Perkins. 1984. Identification of an infective stage of Leishmania promastigotes. Science 223: 1417-9.
18. Afonso, L. C., T. M. Scharton, L. Q. Vieira, M. Wysocka, G. Trinchieri, and P. Scott. 1994. The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science 263: 235-7.
19. Scott, P., E. Pearce, P. Natovitz, and A. Sher. 1987. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes. J. Immunol. 139: 221-7.
20. Mosmann, T. R., and T. A. Fong. 1989. Specific assays for cytokine production by T cells. J. Immunol Methods 116: 151-8.
21. Morris, S. C., K. B. Madden, J. J. Adamovicz, W. C. Gause, B. R. Hubbard, M. K. Gately, and F. D. Finkelman. 1994. Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J. Immunol 152: 1047-56.
22. + effector cells default to the Th2 pathway in Interferon γ-deficient mice infected with Leishmania major. J. Exp. Med. 179: 1367-71.
23. 1 mice infected with Leishmania major. Parasite Immunol. 17: 569-79.
24. Guy, R. A., and M. Belosevic. 1993. Comparison of receptors required for entry of Leishmania major amastigotes into macrophages. Infect. Immun. 61: 1553-8.
25. Peters, C., T. Aebischer, Y. D. Stierhof, M. Fuchs, and P. Overath. 1995. The role of macrophage receptors in adhesion and uptake of Leishmania mexicana amastigotes. J. Cell Sci. 108: 3715-24.
26. Love, D. C., M. Mentink Kane, and D. M. Mosser. 1998. Leishmania amazonensis: the phagocytosis of amastigotes by macrophages. Exp. Parasitol. 88: 161-71.
27. Groux, H., FA. Cottrez, M. Rouleau, S. Mauze, S. Antonenko, S. Hurst, T. McNeil, M. Bigler, M. G. Roncarolo, and R. L. Coffman. 1999. A transgenic model to analyze the immunoregulatory role of IL-10 secreted by antigen-presenting cells. J. Immunol. 162: 1723-9.
28. Belkaid, Y., K. F. Hoffmann, S. Mendez, S. Kamhawi, M. C. Udey, T. A. Wynn, and D. L. Sacks. 2001. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194: 1497-506.
29. Murphy, M. L., U. Wille, E. N. Villegas, C. A. Hunter, and J. P. Farrell. 2001. IL-10 mediates susceptibility to Leishmania donovani infection. Eur. J. Immunol. 31: 2848-56.
30. Padigel, U. M., J. Alexander, and J. P. Farrell. 2003. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J. Immunol 171: 3705-10.
31. Li, J., C. A. Hunter, and J. P. Farrell. 1999. Anti-TGF-β treatment promotes rapid healing of Leishmania major infection in mice by enhancing in vivo nitric oxide production. J. Immunol. 162: 974-9.
32. Gomes, N. A., C. R. Gattass, V. Barreto-De-Souza, M. E. Wilson, and G. A. DosReis. 2000. TGF-β mediates CTLA-4 suppression of cellular immunity in murine kalaazar. J. Immunol. 164: 2001-8.
33. Kurosaka, K., N. Watanabe, and Y. Kobayashi. 2002. Potentiation by human serum of anti-inflammatory cytokine production by human macrophages in response to apoptotic cells. J. Leukocyte Biol. 71: 950-6.
34. Maeda, H., H. Kuwahara, Y. Ichimura, M. Ohtsuki, S. Kurakata, and A. Shiraishi. 1995. TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J. Immunol. 155: 4926-32.
35. + regulatory T cells control Leishmania major persistence and immunity. Nature 420: 502-7.